Results 131 to 140 of about 68,959 (168)
Some of the next articles are maybe not open access.

Disseminated Intravascular Coagulation with the Peritoneovenous Shunt

Annals of Internal Medicine, 1979
Coagulation data were collected before and after peritoneovenous shunting for intractable ascites in 19 shunting procedures. After insertion of the shunts, changes consistent with disseminated intravascular coagulation developed in all cases in which good flow of ascitic fluid was obtained.
D C, Harmon   +3 more
openaire   +2 more sources

Radionuclide Detection of Peritoneovenous Shunt Patency

Clinical Nuclear Medicine, 2003
The Denver peritoneovenous shunt, implanted for cirrhosis-related intractable ascites, appears to provide effective palliation in the majority of patients. A 53-year-old man had hepatitis B virus-related liver cirrhosis with multifocal hepatocellular carcinoma. Two months after injection with I-131 lipiodol he developed acute ascites decompensation and
Filip, Gemmel   +6 more
openaire   +2 more sources

Peritoneovenous shunting for nongynecologic malignant ascites

Cancer, 2001
The development of malignant ascites has been associated with a poor prognosis. Previous reports have documented high morbidity rates associated with placement of palliative peritoneovenous shunts (PVS). Most study series have included gynecologic malignancies in their analysis, and wide variations in survival time have been reported.
S C, Bieligk, B F, Calvo, D G, Coit
openaire   +2 more sources

Radiography of LeVeen type peritoneovenous shunts

American Journal of Roentgenology, 1978
Peritoneovenous shunts of the LeVeen type have been used for several years for relief of intractable ascites [1]. These shunts consist of silastic tubing extending from the peritoneal cavity subcutaneously into the jugular vein and from there into the superior vena cava.
D B, Freiman   +3 more
openaire   +2 more sources

Peritoneovenous (LeVeen) Shunt

JAMA, 1978
Because of the unusual clinical course of a patient with hepatic cirrhosis, refractory ascites, and hepatorenal syndrome, we were able to examine the complex interrelationships between massive ascites, renin-aldosterone activity, and renal and hepatic function before and after placement of a peritoneojugular vein (LeVeen) shunt.
openaire   +1 more source

Neck “Ascites” After Peritoneovenous Shunt

Journal of Clinical Gastroenterology, 1990
We report a patient in whom the placement of a LeVeen shunt lead to the development of "ectopic ascites" in the neck. This previously unreported complication of the peritoneovenous shunt may have been due to the leakage of ascites across the surgical wound. Removing ascites prior to constructing the shunt may prevent this complication.
A, Ginès   +5 more
openaire   +2 more sources

Effects of peritoneovenous shunting on body composition

Gastroenterology, 1986
The effect of peritoneovenous shunting on body composition has been studied in 7 cirrhotic patients undergoing a successful shunt and 3 patients in whom the shunt was unsuccessful. In the 7 patients with functioning shunts, their weight had decreased by a mean of 9 kg (p less than 0.001) by 6 wk after initial diuresis, natriuresis, and kaliuresis, and ...
L M, Blendis   +6 more
openaire   +2 more sources

A new peritoneovenous shunt.

Surgery, 1986
For today's most common peritoneovenous shunt catheters, the high incidence of complications (disseminated intravascular coagulation [DIC], pulmonary problems, clotting of the intravascular end, and shunt kinking) results in limited use. We have designed a new peritoneovenous shunt catheter in which we improved mechanical biocompatibility with respect ...
E, Guzman   +4 more
openaire   +1 more source

Peritoneovenous shunts palliate malignant ascites

The American Journal of Surgery, 1989
Fifty-five peritoneovenous shunts (PVS) were implanted in 45 patients (29 LeVeen and 26 Denver shunts). Seventy-five percent of patients experienced relief of symptoms referable to their ascites. The mean survival time post-shunt placement was 33 weeks; however, considerable variation was noted in survival times for the various tumor types (pancreas 7 ...
J A, Edney, A, Hill, D, Armstrong
openaire   +2 more sources

Peritoneovenous Shunting in the Management of Malignant Ascites

Archives of Surgery, 1979
The incapacitating, malignant ascites of 37 patients were treated with peritoneovenous shunt using the LeVeen valve. Palliation of ascites was achieved in 27 of 37 patients until they died of their underlying diseases. In ten of the 37 patients, no long-term palliation was accomplished.
A K, Straus, D L, Roseman, T M, Shapiro
openaire   +2 more sources

Home - About - Disclaimer - Privacy